Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
A case of chemotherapy-induced menopause left unmanaged for six years prompted a physician’s pointed critique of survivorship care failures, highlighting the clinical and legal stakes of untreated premature ovarian insufficiency following gonadotoxic therapy.
Obstetrics & Gynecology June 17th 2026
Sleep-Wake Advisor
More than half of women aged 50–80 reported sleep problems in a cross-sectional survey analysis, with symptomatic menopausal women significantly more likely to be affected than those without menopausal symptoms.
Internal Medicine June 17th 2026
Conexiant
Nearly 18 million US women aged 45–64 were overdue for at least one recommended breast, cervical, or colorectal cancer screening, with colorectal cancer representing the largest unmet need in a 2024 BRFSS analysis of 36.2 million women.
Family Medicine/General Practice June 17th 2026
Hematopoietic loss of the X chromosome in peripheral blood was associated with more than twofold the odds of failing to conceive naturally in a Japanese multicenter case-control study, with no corresponding association found in women undergoing ART.
Obstetrics & Gynecology June 2nd 2026
A 14-year international consensus effort involving 56 professional and patient organizations has renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, a shift designed to better reflect the condition’s systemic hormonal and metabolic pathophysiology.
Endocrinology, Diabetes, Metabolism June 2nd 2026
Healthline
A randomized phase II trial in 240 premenopausal women evaluated whether low-dose (Z)-endoxifen could reduce mammographic breast density with improved tolerability compared with standard tamoxifen prevention regimens.
Family Medicine/General Practice May 20th 2026